This proposal, in response to RFA:CA-91-32, describes a Clinical and Molecular Cancer Research Training (CMCRT) Program at Memorial Sloan-Kettering Cancer Center. The object of this training program is to provide clinical oncology trainees with both laboratory and clinical investigation skills that will enable them to develop full-time academic careers targeted upon moving new findings in molecular and cell biology, as well as immunology and pharmacology, from the research laboratory into clinical trials. The training program will be directed by the chairmen of the five clinical departments with patient-care responsibilities at Memorial Hospital: Medicine, Surgery, Radiation Oncology, Pediatrics, and Neurology. Twenty mentors (or mentor pairs) have been selected to direct the research activities of the trainees. The curriculum includes laboratory research, writing and executing clinical trials, and participation in educational seminars and lectures. The initial number of trainees is six per year, and this is projected to increase to 12 per year (allowing for six in the first year of the program and six in the second year of the program). Trainees may remain in the program for up to four years, supported by other sources of funds, until they are ready to initiate independent academic research programs. Memorial Sloan-Kettering Cancer Center provides an outstanding interdisciplinary clinical research environment in which to pursue the goals of this training program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12CA001712-03
Application #
2084340
Study Section
Special Emphasis Panel (SRC (72))
Project Start
1992-09-11
Project End
1997-08-31
Budget Start
1994-09-01
Budget End
1995-08-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Vazquez, Alexei; Tedeschi, Philip M; Bertino, Joseph R (2013) Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumors. Cancer Res 73:478-82
Ferrone, Cristina R; Perales, Miguel-Angel; Goldberg, Stacie M et al. (2006) Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains. Clin Cancer Res 12:5511-9
Srinivasan, Roopa; Houghton, Alan N; Wolchok, Jedd D (2002) Induction of autoantibodies against tyrosinase-related proteins following DNA vaccination: unexpected reactivity to a protein paralogue. Cancer Immun 2:8
Perales, Miguel-Angel; Wolchok, Jedd D (2002) Melanoma vaccines. Cancer Invest 20:1012-26
Perales, Miguel-Angel; Fantuzzi, Giamila; Goldberg, Stacie M et al. (2002) GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: implications for DNA vaccines. Cytokines Cell Mol Ther 7:125-33
Perales, Miguel-Angel; Blachere, Nathalie E; Engelhorn, Manuel E et al. (2002) Strategies to overcome immune ignorance and tolerance. Semin Cancer Biol 12:63-71
Noy, A; Verma, R; Glenn, M et al. (2001) Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol. Blood 97:1929-36
Wolchok, J D; Srinivasan, R; Perales, M A et al. (2001) Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens. Cancer Immun 1:9
Araten, D J; Nafa, K; Pakdeesuwan, K et al. (1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A 96:5209-14
Lonardo, F; Rusch, V; Langenfeld, J et al. (1999) Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res 59:2470-6

Showing the most recent 10 out of 21 publications